Operation Warp Speed expects that the U.S. trials of vaccines made by AstraZeneca Plc and Johnson & Johnson to restart as soon as this week. The two companies developing Covid-19 vaccines backed by Operation Warp Speed temporarily halted their trials because participants fell ill, slowing down the race for a shot to halt the pandemic. J&J paused its trial last week when a participant got sick. AstraZeneca’s trial paused last month after a woman in the U.K. study developed neurological symptoms and the U.S. Food & Drug Administration has yet to clear the study to resume in the U.S. Johnson & Johnson is testing its vaccine in as many as 60,000 volunteers from Peru to South Africa. U.S. regulators have not put a clinical hold on J&J’s trial. British drugmaker Astra and partner the University of Oxford last month temporarily stopped tests of its own vaccine candidate after a trial participant fell ill. While the Astra study has remained halted in the U.S., where it is being evaluated by regulators, it has resumed in a number of other countries.
SOURCE: AL JAZEERA
More Stories
Tough Times Lie Ahead for Banks in Africa
The Most Prominent Challenge Female Entrepreneurs Face across Sub-Saharan Africa
Egypt to Raise Transit Fees in 2023 for all Types of Vessels Passing through the Suez Canal
Malawi Remains the World’s Poorest Peaceful Country
AfDB On How South Africa Should Use its Climate Funding
Can Nigeria’s National Carrier Rise from the Ashes?
Africa’s Top Mobile Internet Speed Falls Short of the Global Average
South Africa’s Latest Rolling Blackouts Takes its Toll on Fundamental Sectors of the Economy
Rallying Around Zimbabwe’s Economy
African Currencies are Depreciating against the Dollar
Movie about a Malawian Farmer and her Efforts to Change Minds in her Village and in the US
DRC’s Urban Regeneration